DOI QR코드

DOI QR Code

Recombinant Human Laforin Expressed in Insect Cells: Expression, Purification, and Biochemical Characterizations

단신 (Notes)

Choi, Ji-Woong;Bong, Seoung Min;Yang, Seung Won;Jang, Hyonchol;Park, SangYoun;Kim, Seung Jun;Lee, Byung Il

  • Received : 2015.06.10
  • Accepted : 2015.07.20
  • Published : 2015.10.20

Abstract

Keywords

Laforin;EPM2A;Baculovirus;Insect cells;Phosphatase;Glycogen;Lafora disease

References

  1. Brewer, M. K.; Husodo, S.; Dukhande, V. V.; Johnson, M. B.; Gentry, M. S., Expression, purification and characterization of soluble red rooster laforin as a fusion protein in Escherichia coli. BMC biochemistry 2014, 15(1), 8. https://doi.org/10.1186/1471-2091-15-8
  2. Jarvis, D. L., Baculovirus Expression Vectors. In The Baculoviruses; Plenum Press: New York, 1997, Miller, L.K., Ed.; pp 389-431.
  3. Roma-Mateo, C.; Solaz-Fuster Mdel, C.; Gimeno-Alcaniz, J. V.; Dukhande, V. V.; Donderis, J.; Worby, C. A.; Marina, A.; Criado, O.; Koller, A.; Rodriguez De Cordoba, S.; Gentry, M. S.; Sanz, P., Biochem. J. 2011, 439(2), 265. https://doi.org/10.1042/BJ20110150
  4. Raththagala, M.; Brewer, M. K.; Parker, M. W.; Sherwood, A. R.; Wong, B. K.; Hsu, S.; Bridges, T. M.; Paasch, B. C.; Hellman, L. M.; Husodo, S.; Meekins, D. A.; Taylor, A. O.; Turner, B. D.; Auger, K. D.; Dukhande, V. V.; Chakravarthy, S.; Sanz, P.; Woods, V. L., Jr.; Li, S.; Vander Kooi, C. W.; Gentry, M. S., Mol. Cell 2015, 57(2), 261. https://doi.org/10.1016/j.molcel.2014.11.020
  5. Wang, J.; Stuckey, J. A.; Wishart, M. J.; Dixon, J. E., A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen. J. Biol. Chem. 2002, 277(4), 2377. https://doi.org/10.1074/jbc.C100686200
  6. Cantarel, B. L.; Coutinho, P. M.; Rancurel, C.; Bernard, T.; Lombard, V.; Henrissat, B., The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics. Nucleic Acids Res. 2009, 37 (Database issue), D233. https://doi.org/10.1093/nar/gkn663
  7. Ganesh, S.; Tsurutani, N.; Suzuki, T.; Hoshii, Y.; Ishihara, T.; Delgado-Escueta, A. V.; Yamakawa, K., The carbohydratebinding domain of Lafora disease protein targets Lafora polyglucosan bodies. Biochem. Biophys. Res. Commun. 2004, 313(4), 1101. https://doi.org/10.1016/j.bbrc.2003.12.043
  8. Tonks, N. K., Protein tyrosine phosphatases: from genes, to function, to disease. Nature Reviews. Mol. Cell Biology 2006, 7(11), 833.
  9. Alonso, A.; Sasin, J.; Bottini, N.; Friedberg, I.; Friedberg, I.; Osterman, A.; Godzik, A.; Hunter, T.; Dixon, J.; Mustelin, T., Protein tyrosine phosphatases in the human genome. Cell 2004, 117(6), 699. https://doi.org/10.1016/j.cell.2004.05.018
  10. Tagliabracci, V. S.; Heiss, C.; Karthik, C.; Contreras, C. J.; Glushka, J.; Ishihara, M.; Azadi, P.; Hurley, T. D.; DePaoliRoach, A. A.; Roach, P. J., Phosphate incorporation during glycogen synthesis and Lafora disease. Cell Metab. 2011, 13(3), 274. https://doi.org/10.1016/j.cmet.2011.01.017
  11. Girard, J. M.; Le, K. H.; Lederer, F., Molecular characterization of laforin, a dual-specificity protein phosphatase implicated in Lafora disease. Biochimie 2006, 88(12), 1961. https://doi.org/10.1016/j.biochi.2006.08.002
  12. Dukhande, V. V.; Rogers, D. M.; Roma-Mateo, C.; Donderis, J.; Marina, A.; Taylor, A. O.; Sanz, P.; Gentry, M. S., Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activity. PloS one 2011, 6(8), e24040. https://doi.org/10.1371/journal.pone.0024040
  13. (a) Gentry, M. S.; Roma-Mateo, C.; Sanz, P., Laforin, a protein with many faces: glucan phosphatase, adapter protein, et alii. The FEBS Journal 2013, 280(2), 525; https://doi.org/10.1111/j.1742-4658.2012.08549.x
  14. (b) Gentry, M. S.; Dixon, J. E.; Worby, C. A., Lafora disease: insights into neurodegeneration from plant metabolism. Trends Biochem. Sci. 2009, 34(12), 628. https://doi.org/10.1016/j.tibs.2009.08.002
  15. Ganesh, S.; Puri, R.; Singh, S.; Mittal, S.; Dubey, D., Recent advances in the molecular basis of Lafora’s progressive myoclonus epilepsy. J. Hum. Genet. 2006, 51(1), 1. https://doi.org/10.1007/s10038-005-0321-1
  16. Tagliabracci, V. S.; Turnbull, J.; Wang, W.; Girard, J. M.; Zhao, X.; Skurat, A. V.; Delgado-Escueta, A. V.; Minassian, B. A.; Depaoli-Roach, A. A.; Roach, P. J., Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(49), 19262. https://doi.org/10.1073/pnas.0707952104
  17. Minassian, B. A.; Lee, J. R.; Herbrick, J. A.; Huizenga, J.; Soder, S.; Mungall, A. J.; Dunham, I.; Gardner, R.; Fong, C. Y.; Carpenter, S.; Jardim, L.; Satishchandra, P.; Andermann, E.; Snead, O. C., 3rd; Lopes-Cendes, I.; Tsui, L. C.; DelgadoEscueta, A. V.; Rouleau, G. A.; Scherer, S. W., Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat. Genet. 1998, 20(2), 171. https://doi.org/10.1038/2470